Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies

Rheumatology (Oxford). 2020 Apr 1;59(4):917. doi: 10.1093/rheumatology/kez609.
No abstract available

Publication types

  • Published Erratum